{"filings":[{"id":591681,"accession_number":"0001193125-26-235496","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2026-05-22T12:00:11+00:00","items":["5.07","7.01","9.01"],"status":"ready","headline":"Henry Schein elects William K. Daniel as Independent Chairman; Bergman retires","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["William K. Daniel elected Independent Chairman effective May 21, 2026.","Stanley M. Bergman retired from Board after 44 years, named Chairman Emeritus.","Daniel joined board in May 2025; former Danaher EVP overseeing dental portfolio.","CEO Fred Lowery thanked Bergman for transformative leadership and welcomed Daniel."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":90484,"accession_number":"0001000228-26-000021","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2026-05-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Henry Schein Q1 GAAP EPS $0.92, non-GAAP $1.32; reaffirms 2026 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 GAAP diluted EPS $0.92 vs $0.88 YoY; non-GAAP diluted EPS $1.32 vs $1.15 YoY.","Net sales $3.4B, up 6.3% (2.5% internal growth); Adjusted EBITDA $289M vs $259M.","Reaffirmed 2026 guidance: non-GAAP EPS $5.23-$5.37, sales growth 3%-5%.","Repurchased 1.6M shares for $125M at avg $77.64; $655M remaining authorization.","Value creation initiatives targeting $200M+ operating income improvement; $125M run-rate by end-2026."],"consensus_eps_estimate":null,"consensus_eps_actual":0.92,"consensus_revenue_estimate":null,"consensus_revenue_actual":3368000000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":100030,"accession_number":"0001000228-26-000010","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2026-02-24T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Henry Schein Q4 sales +7.7%, non-GAAP EPS $1.34; 2026 guide $5.23-$5.37","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 GAAP EPS $0.85 vs $0.74; non-GAAP EPS $1.34 vs $1.19; total sales $3.4B (+7.7% YoY, internal 4.9%).","Global Dental equipment sales +12.2%; Specialty Products +14.6%; Technology +8.4% in Q4.","Full year 2025 sales $13.2B (+4.0%); non-GAAP EPS $4.97 vs $4.74; Adjusted EBITDA $1,101M.","2026 non-GAAP EPS guidance $5.23-$5.37; sales growth 3-5%; Adjusted EBITDA mid-single-digit growth.","Fred Lowery to join as CEO next week; repurchased $850M of shares in 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":3.27,"consensus_revenue_estimate":null,"consensus_revenue_actual":13184000000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":100029,"accession_number":"0001193125-26-009725","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2026-01-12T23:59:59+00:00","items":["5.02","5.03","9.01"],"status":"ready","headline":"Henry Schein names Frederick Lowery as CEO effective March 2, 2026; Bergman remains Chairman","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Frederick Lowery (ex-Thermo Fisher EVP) succeeds Stanley Bergman as CEO; Bergman continues as Chairman.","Lowery receives $1.25M base salary, target bonus 150% of base, 2026 minimum bonus $1.875M.","2026 equity awards target value $10M (50% options, 25% RSUs, 25% performance RSUs); sign-on grant $2.5M.","Bylaws amended to eliminate requirement that CEO also be President or Chairman.","Amended executive severance plan now includes CEO eligibility for non-CIC severance benefits."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":116377,"accession_number":"0001193125-25-330853","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2025-12-23T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Henry Schein expects to name next CEO by mid-January 2026; Bergman remains until successor assumes role","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Board expects to appoint next CEO by mid-January 2026; search process nearing completion.","Stanley Bergman continues as CEO & Chairman until successor assumes the position.","Bergman entered into letter agreement extending employment until earlier of new CEO start or 30 days after his notice.","Search evaluated highly qualified candidates; Board expects final decision soon."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":116376,"accession_number":"0001193125-25-329486","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2025-12-23T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Henry Schein extends private shelf facility termination dates to Dec 19, 2028","summary_kind":"llm","event_type":"debt","confidence":"medium","bullets":["Amended shelf agreements with Prudential, NYL, MetLife, and Corebridge to extend termination to Dec 19, 2028.","Modifications made to certain financial definitions and covenants.","No new borrowing amount or interest rate changes disclosed in the filing.","Amendment covers the existing private shelf facilities; no material change in financial obligations."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":116375,"accession_number":"0001193125-25-311953","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2025-12-09T23:59:59+00:00","items":["1.01"],"status":"ready","headline":"KKR designees Lin & Daniel to be renominated to Henry Schein board for 2026 annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["KKR notified Henry Schein on Dec 7, 2025 of election to exercise Extension Election under Jan 29, 2025 Strategic Partnership Agreement.","Board will renominate Max Lin and William K. Daniel for election at 2026 Annual Meeting for a one-year term.","Extension Election is a contractual right of KKR as Investor Representative under the agreement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":116374,"accession_number":"0001000228-25-000063","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2025-11-04T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Henry Schein Q3 2025 non-GAAP EPS $1.38 vs $1.22; raises FY guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 GAAP EPS $0.84 vs $0.78; non-GAAP EPS $1.38 vs $1.22; revenue $3.3B up 5.2% YoY.","Raises 2025 non-GAAP EPS guidance to $4.88-$4.96 (from $4.80-$4.94) and sales growth to 3-4% (from 2-4%).","Announces value creation initiatives targeting >$200M operating income improvement over next few years.","Board approved amendment allowing KKR to increase ownership up to 19.9%; KKR can buy open market.","Repurchased 3.3M shares for $229M in Q3; $980M remains authorized for future buys."],"consensus_eps_estimate":null,"consensus_eps_actual":2.42,"consensus_revenue_estimate":null,"consensus_revenue_actual":9747000000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":132821,"accession_number":"0001193125-25-199164","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2025-09-09T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"James Breslawski leaves Henry Schein advisor role; receives severance","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["James Breslawski transitioned from President to Senior Advisor on April 1, 2025.","He left that role effective September 5, 2025.","Breslawski will receive payments and benefits under the Executive Severance Plan."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":132820,"accession_number":"0001000228-25-000042","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2025-08-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Henry Schein Q2 GAAP EPS $0.70 (down 12.5% YoY); maintains FY25 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 GAAP net income $86M ($0.70 diluted EPS) vs $104M ($0.80) YoY; non-GAAP EPS $1.10 vs $1.23.","Total sales $3.2B, up 3.3% as-reported; internal growth 1.9%; Global Medical Distribution up 6.1%.","Adjusted EBITDA $256M vs $268M; recorded $23M restructuring costs targeting $100M+ annual run-rate savings.","FY25 guidance maintained: non-GAAP diluted EPS $4.80-$4.94, sales growth 2%-4%, mid-single digit Adj. EBITDA growth.","Repurchased ~3.7M shares for $259M in Q2; $432M remaining for future repurchases."],"consensus_eps_estimate":null,"consensus_eps_actual":1.58,"consensus_revenue_estimate":null,"consensus_revenue_actual":6408000000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":132819,"accession_number":"0001193125-25-159019","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2025-07-15T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Stanley M. Bergman to retire as Henry Schein CEO at end of 2025; will remain Chairman","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Bergman to retire as CEO effective Dec 31, 2025, after 45 years at the company, over 35 as CEO.","Board initiates formal CEO search with external firm, considering internal and external candidates.","Bergman will remain Chairman of the Board following his retirement.","Under Bergman, revenue grew from $225M (1989) to ~$13B (2024), a 17.5% CAGR; market cap from $290M (IPO 1995) to ~$9B.","Company cites strong management in place; Andrea Albertini (Global Distribution/Technology) and Tom Popeck (Health Care Specialties) lead divisions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":149368,"accession_number":"0001193125-25-137473","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2025-06-09T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Henry Schein amends $750M term loan and $1B revolver, extends maturity to 2030","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Amended and restated $750M term loan credit agreement, extending termination date to June 6, 2030.","Also amended and restated $1B revolving credit facility; modified financial definitions and covenants.","Proceeds for working capital, corporate purposes, stock repurchases, refinancing, and acquisitions.","Term loan jointly led by JPMorgan and U.S. Bank; revolver arranged by same syndicate plus additional co-documentation agents."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":149367,"accession_number":"0001193125-25-125917","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2025-05-23T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Henry Schein shareholders elect all 12 directors, approve say-on-pay and auditor ratification","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All 12 incumbent directors elected; Philip Laskawy received 20.6M against votes but still elected.","Max Lin and William K. 'Dan' Daniel elected as directors for terms expiring 2026.","Non-binding say-on-pay approved with 93.3M for, 12.2M against, 3.3M abstain.","Ratification of BDO USA as independent auditor for FY2025 passed with 107.9M for, 3.4M against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":149366,"accession_number":"0001193125-25-121679","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2025-05-16T23:59:59+00:00","items":["1.01","3.02","5.02","7.01","9.01"],"status":"ready","headline":"Henry Schein closes $250M KKR investment; Dan Daniel joins board","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["KKR invested $250M for ~12% of HSIC common shares at ~$76.10/share in private placement.","William K. 'Dan' Daniel appointed as independent director effective May 16; joins Compensation and Strategic Advisory committees.","Max Lin, KKR partner, joined board May 2; appointed to Nominating & Governance and Strategic Advisory committees.","Transaction closed after expiration of HSR waiting period and regulatory approvals in Sweden, Italy, and Spain.","Proceeds expected to support HSIC's BOLD+1 strategy; no change to financial guidance."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":149365,"accession_number":"0001140361-25-017199","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2025-05-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Henry Schein Q1 GAAP EPS $0.88 (+22% YoY); non-GAAP EPS $1.15 (+4.5%); maintains FY guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 net sales $3.2B; constant currency sales up 1.4% (2.0% ex-PPE/COVID test kits).","Global Distribution sales +0.8% constant currency; Medical +3.0%, Specialty +4.3%.","Repurchased $161M of stock (~2.3M shares at avg $71.58); $718M remaining authorization.","Restructuring costs $25M in Q1; expects annual run-rate savings at high end of $75M-$100M by end-2025.","FY2025 guidance unchanged: non-GAAP EPS $4.80-$4.94, sales growth 2%-4%, mid-single digit EBITDA growth."],"consensus_eps_estimate":null,"consensus_eps_actual":0.88,"consensus_revenue_estimate":null,"consensus_revenue_actual":3168000000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":149364,"accession_number":"0001193125-25-111677","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2025-05-02T23:59:59+00:00","items":["1.01","5.02","9.01"],"status":"ready","headline":"Henry Schein appoints KKR partner Max Lin to board; removes KKR voting commitment","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Max Lin, a KKR partner and head of Americas Health Care Private Equity, appointed to board effective May 2, 2025.","Board size increased to 15 directors; Lin will serve on Nominating/Governance and Strategic Advisory committees.","Regulatory conditions (HSR, Sweden/Italy approvals) for Lin's appointment satisfied as of April 10, 2025.","Lin receives standard non-employee director cash compensation (payable to KKR) but no equity grants.","Letter agreement deletes Section 5.11 of the KKR Strategic Partnership Agreement, removing investor's voting commitment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":149363,"accession_number":"0001193125-25-080753","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2025-04-15T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Henry Schein adopts executive severance plan with 1.5x multiple for officers; revises change-in-control plan","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Compensation Committee approved Executive Severance Plan effective April 10, 2025, covering members of Executive Management Committee (except CEO).","Severance multiples: 1.5x base salary+avg bonus for executive officers; 1.0x for others; paid over severance period.","Requires release of claims; includes pro-rata bonus, equity acceleration, COBRA subsidy up to 18 months, outplacement.","Contains non-compete, non-solicit, non-disparage covenants; violation triggers forfeiture and recoupment.","Amended CIC Plan adds non-duplication language to reduce benefits by any severance already paid under Severance Plan."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":149362,"accession_number":"0001193125-25-076218","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2025-04-09T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Henry Schein amends KKR voting commitment; allows KKR to follow ISS/Glass Lewis if Board differs","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Letter dated April 7, 2025 modifies the Jan 29, 2025 Strategic Partnership Agreement.","If both ISS and Glass Lewis recommend differently from Board on a stockholder proposal (excluding director elections/removals), KKR may vote its own discretion.","No other terms of the Partnership Agreement were amended or waived.","The amendment applies to all stockholder meetings during the Term, including written consents."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":168439,"accession_number":"0001193125-25-054483","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2025-03-14T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Henry Schein President Breslawski transitions to Senior Advisor effective April 1, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["James P. Breslawski steps down as President of Henry Schein effective April 1, 2025.","He will serve as Senior Advisor and remain on the Executive Management Committee.","No successor named; company retains Breslawski in advisory capacity.","Transition is effective April 1, 2025, as reported March 11, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":168438,"accession_number":"0001000228-25-000010","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2025-02-25T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Henry Schein Q4 2024 non-GAAP EPS $1.19 vs $0.66; guides 2025 EPS $4.80-$4.94","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $3.2B (+5.8% YoY); non-GAAP diluted EPS $1.19 (prior year $0.66).","Full-year 2024 non-GAAP EPS $4.74, revenue $12.7B; operating cash flow $848M, up $348M.","2025 non-GAAP EPS guidance $4.80-$4.94 (1-4% growth); sales growth ~2-4%.","New segments: Global Distribution & Value-Added ($10.8B), Specialty Products ($1.4B), Technology ($0.6B).","Restructuring $37M in Q4; expects $75-100M annual run-rate savings by end of 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":3.05,"consensus_revenue_estimate":null,"consensus_revenue_actual":12673000000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":168437,"accession_number":"0001193125-25-015654","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2025-01-29T23:59:59+00:00","items":["1.01","2.02","3.02","5.02","7.01","9.01"],"status":"ready","headline":"Henry Schein announces $250M KKR investment, preliminary Q4 EPS $1.19, and 2025 guidance","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["KKR to invest $250M at ~$76.10/share, becoming 12% common shareholder with board seats.","Preliminary Q4 2024: GAAP EPS $0.74, non-GAAP EPS $1.19; revenue $3.2B.","Full-year 2024 non-GAAP EPS $4.74; Adjusted EBITDA $1.061B.","2025 guidance: low-to-mid single-digit revenue and non-GAAP EPS growth; mid-single-digit EBITDA growth.","Board adds KKR designees Max Lin and William Daniel, plus independent director Robert Hombach; buyback authorization raised by $500M."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":185564,"accession_number":"0001000228-24-000062","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2024-11-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Henry Schein Q3 GAAP EPS $0.78, non-GAAP $1.22; raises FY2024 non-GAAP EPS guidance to $4.74-$4.82","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total net sales $3.2B, up 0.4% YoY; internal sales down 2.6% reflecting cyber incident recovery and lower PPE sales.","Non-GAAP diluted EPS $1.22 vs $1.32 YoY; GAAP diluted EPS $0.78 vs $1.05 YoY.","Operating cash flow $151M in Q3; year-to-date $644M, up $112M vs 2023.","Raised FY2024 non-GAAP EPS guidance to $4.74-$4.82 (from $4.70-$4.82) and reaffirmed low-double-digit Adjusted EBITDA growth.","Recorded $48M restructuring costs in Q3; new 2024/2025 plan targeting $75-$100M annual run-rate savings by end of 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":2.3,"consensus_revenue_estimate":null,"consensus_revenue_actual":9482000000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":202149,"accession_number":"0001000228-24-000051","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2024-08-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Henry Schein Q2 GAAP EPS $0.80 vs $1.06 YoY; lowers FY24 guidance, announces restructuring","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 total sales $3.1B (+1.1% YoY); internal sales down 2.4%.","GAAP diluted EPS $0.80; non-GAAP diluted EPS $1.23 vs $1.31 prior year.","FY24 non-GAAP EPS guidance cut to $4.70–$4.82 from $5.00–$5.16; sales growth lowered to ~4-6% from 8-10%.","New restructuring plan targets $75M–$100M annual run-rate savings.","Board authorized additional $500M share repurchase program."],"consensus_eps_estimate":null,"consensus_eps_actual":1.52,"consensus_revenue_estimate":null,"consensus_revenue_actual":6308000000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":218199,"accession_number":"0001193125-24-147029","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2024-05-24T23:59:59+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"Stockholders approve amended 2024 Stock Incentive Plan with 4.8M new shares","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Aggregate share reserve increased by 4,800,000 shares to a maximum of 75,742,657 shares.","Individual participant annual limit raised to 750,000 shares from prior limit.","Plan term extended to March 31, 2034 (previously March 31, 2030).","Clawback provisions added, including Dodd-Frank Clawback Policy effective Dec 1, 2023.","All 13 director nominees elected; say-on-pay approved (101.4M for, 13.9M against)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":218198,"accession_number":"0001000228-24-000022","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2024-05-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Henry Schein Q1 sales $3.2B, GAAP EPS $0.72; tightens 2024 sales growth guidance to 8-10%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 total sales $3.2B (+3.7% YoY); internal sales -1.8% due to cyber incident (300-400 bps drag) and lower glove pricing.","GAAP diluted EPS $0.72 vs $0.91 YoY; non-GAAP diluted EPS $1.10 vs $1.21 YoY.","Adjusted EBITDA $255M, flat YoY; 2024 Adj. EBITDA growth >15% reaffirmed.","2024 non-GAAP EPS guidance reaffirmed at $5.00-$5.16; total sales growth guidance narrowed to 8%-10% from 8%-12%.","Repurchased ~1M shares for $75M at avg $75.10; $190M remaining authorization."],"consensus_eps_estimate":null,"consensus_eps_actual":0.72,"consensus_revenue_estimate":null,"consensus_revenue_actual":3172000000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":238173,"accession_number":"0001000228-24-000008","cik":1000228,"company_name":"HENRY SCHEIN INC","ticker":"HSIC","form_type":"8-K","filed_at":"2024-02-27T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Henry Schein Q4 GAAP EPS $0.13, non-GAAP $0.66; guides 2024 EPS $5.00-$5.16","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net sales $3.0B (-10.5% YoY); estimated $350M-$400M reduction from cybersecurity incident.","Q4 GAAP diluted EPS $0.13; non-GAAP diluted EPS $0.66, reflecting $0.70-$0.75 cyber impact.","Full-year 2023: revenue $12.3B, GAAP EPS $3.16, non-GAAP EPS $4.50.","2024 guidance: non-GAAP EPS $5.00-$5.16 (11%-15% growth); sales growth ~8%-12%; Adjusted EBITDA >15% growth.","Residual cyber impact ~$0.15 in Q1 2024; tax rate expected to rise to ~25%."],"consensus_eps_estimate":null,"consensus_eps_actual":3.16,"consensus_revenue_estimate":null,"consensus_revenue_actual":12339000000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":8620081079.703112,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}